dewittelab

dewittelab.com

Menu

All Publications

  1. Microglia-mediated synaptic pruning as a key deficit in neurodevelopmental disorders: Hype or hope? Mordelt A & de Witte LD. Current Opinion in Neurobiology. 2023. 79, S. 102674.
  2. Lower fractional anisotropy without evidence for neuro-inflammation in patients with early-phase schizophrenia spectrum disorders. Gangadin SS, Mandl RCW, De Witte LD, van Haren NEM, Schutte MJL, Begemann MJH, Kahn RS, Sommer IEC. Schizophr Res. 2022 Dec 26:S0920-9964(22)00456-X.
  3. Cross-sectional associations of maternal PFAS exposure on SARS-CoV-2 IgG antibody levels during pregnancy. Kaur K, Lesseur C, Chen L, Andra SS, Narasimhan S, Pulivarthi D, Midya V, Ma Y, Ibroci E, Gigase F, Lieber M, Lieb W, Janevic T, De Witte LD, Bergink V, Rommel AS, Chen J. Environ Res. 2023 Feb 5;219:115067.
  4. Impact of prenatal COVID-19 vaccination on delivery and neonatal outcomes: Results from a New York City cohort. Ibroci E, Liu X, Lieb W, Jessel R, Gigase FAJ, Chung K, Graziani M, Lieber M, Ohrn S, Lynch J, Castro J, Marshall C, Tubassum R, Mutawakil F, Kaplowitz ET, Ellington S, Molenaar N, Sperling RS, Howell EA, Janevic T, Dolan SM, Stone J, De Witte LD, Bergink V, Rommel AS. Vaccine. 2023 Jan 16;41(3):649-656. doi: 10.1016/j.vaccine.2022.09.095. 
  5. Diagnostic model development for schizophrenia based on peripheral blood mononuclear cell subtype-specific expression of metabolic markers. Zaki JK, Lago SG, Rustogi N, Gangadin SS, Benacek J, van Rees GF, Haenisch F, Broek JA, Suarez-Pinilla P, Ruland T, Auyeung B, Mikova O, Kabacs N, Arolt V, Baron-Cohen S, Crespo-Facorro B, Drexhage HA, De Witte LD, Kahn RS, Sommer IE, Bahn S, Tomasik J. Transl Psychiatry. 2022 Oct 30;12(1):457.
  6. Inflammatory monocyte gene signature predicts beneficial within group effect of simvastatin in patients with schizophrenia spectrum disorders in a secondary analysis of a randomized controlled trial. Aichholzer M, Gangadin SS, Sommer IEC, Wijkhuis A, De Witte LD, Kahn RS, Bahn S, Drexhage HA, Schiweck C. Brain Behav Immun Health. 2022 Nov 8;26:100551.
  7. Impact of prenatal COVID-19 vaccination on delivery and neonatal outcomes: Results from a New York City cohort. Ibroci E, Liu X, Lieb W, Jessel R, Gigase FAJ, Chung K, Graziani M, Lieber M, Ohrn S, Lynch J, Castro J, Marshall C, Tubassum R, Mutawakil F, Kaplowitz ET, Ellington S, Molenaar N, Sperling RS, Howell EA, Janevic T, Dolan SM, Stone J, De Witte LD, Bergink V, Rommel AS. Vaccine. 2022
  8. Cross-sectional associations of maternal PFAS exposure on SARS-CoV-2 IgG antibody levels during pregnancy. Kaur K, Lesseur C, Chen L, Andra SS, Narasimhan S, Pulivarthi D, Midya V, Ma Y, Ibroci E, Gigase F, Lieber M, Lieb W, Janevic T, De Witte LD, Bergink V, Rommel AS, Chen J. Environ Res. 2022 Dec 14;219:115067.
  9. Shock and kill within the CNS: A promising HIV eradication approach? Nühn MM, Gumbs SBH, Buchholtz NVEJ, Jannink LM, Gharu L, De Witte LD, Wensing AMJ, Lewin SR, Nijhuis M, Symons J. J Leukoc Biol. 2022 Sep 23. doi: 10.1002/JLB.5VMR0122-046
  10. Effects of severe acute respiratory syndrome coronavirus 2 infection on obstetric outcomes: Results from a prospective cohort in the Netherlands. Gigase FAJ, Boekhorst MGBM, Rommel AS, Dolan SM, Pop V, Bergink V, De Witte LD. Int J Gynaecol Obstet. 2022 Aug 14
  11. Gestational SARS-CoV-2 infection is associated with placental expression of immune and trophoblast genes. Lesseur C, Jessel RH, Ohrn S, Ma Y, Li Q, Dekio F, Brody RI, Wetmur JG, Gigase FAJ, Lieber M, Lieb W, Lynch J, Afzal O, Ibroci E, Rommel AS, Janevic T, Stone J, Howell EA, Galang RR, Dolan SM, Bergink V, De Witte LD, Chen J. Placenta. 2022 Aug;126:125-132
  12. The translation of genetic risk variants to molecular disease mechanisms. Snijders G, Snijders R, De Witte LD. Tijdschr Psychiatr. 2022;64(5):323-326.
  13. Exposure to the Amino Acids Histidine, Lysine, and Threonine Reduces mTOR Activity and Affects Neurodevelopment in a Human Cerebral Organoid Model. Berdenis van Berlekom A, Kübler R, Hoogeboom JW, Vonk D, Sluijs JA, Pasterkamp RJ, Middeldorp J, Kraneveld AD, Garssen J, Kahn RS, Hol EM, De Witte LD, Boks MP. Nutrients. 2022 May 23;14(10):2175
  14. The influence of structural racism, pandemic stress, and SARS-CoV-2 infection during pregnancy with adverse birth outcomes. Janevic T, Lieb W, Ibroci E, Lynch J, Lieber M, Molenaar NM, Rommel AS, De Witte L, Ohrn S, Carreño JM, Krammer F, Zapata LB, Snead MC, Brody RI, Jessel RH, Sestito S, Adler A, Afzal O, Gigase F, Missall R, Carrión D, Stone J, Bergink V, Dolan SM, Howell EA; Krammer Serology Core Study Group. Am J Obstet Gynecol MFM. 2022 Jul;4(4):100649.
  15. Characterization of HIV-1 Infection in Microglia-Containing Human Cerebral Organoids. Gumbs SBH, Berdenis van Berlekom A, Kübler R, Schipper PJ, Gharu L, Boks MP, Ormel PR, Wensing AMJ, De Witte LD, Nijhuis M. Viruses. 2022 Apr 16;14(4):829.
  16. New insights into the genetic etiology of Alzheimer’s disease and related dementias. Bellenguez C, Küçükali F, Jansen IE, xxxxxxx, Ramirez A, Lambert JC. Nat Genet. 2022 Apr;54(4):412-436
  17. The long-term impact of elevated C-reactive protein levels during pregnancy on brain morphology in late childhood. Suleri A, Blok E, Durkut M, Rommel AS, Witte L, Jaddoe V, Bergink V, White T. Brain Behav Immun. 2022 Jul;103:63-72.
  18. Human microglial models to study HIV infection and neuropathogenesis: a literature overview and comparative analyses. Gumbs SBH, Kübler R, Gharu L, Schipper PJ, Borst AL, Snijders GJLJ, Ormel PR, van Berlekom AB, Wensing AMJ, De Witte LD, Nijhuis M. J Neurovirol. 2022 Feb;28(1):64-91.
  19. Contribution of Age, Brain Region, Mood Disorder Pathology, and Interindividual Factors on the Methylome of Human Microglia. De Witte LD, Wang Z, Snijders GLJL, Mendelev N, Liu Q, Sneeboer MAM, Boks MPM, Ge Y, Haghighi F. Biol Psychiatry. 2022 Mar 15;91(6):572-581.
  20. Dysregulation of mitochondrial and proteolysosomal genes in Parkinson’s disease myeloid cells. Navarro E, Udine E, de Paiva Lopes K, Parks M, Riboldi G, Schilder BM, Humphrey J, Snijders GJL, Vialle RA, Zhuang M, Sikder T, Argyrou C, Allan A, Chao MJ, Farrell K, Henderson B, Simon S, Raymond D, Elango S, Ortega RA, Shanker V, Swan M, Zhu CW, Ramdhani R, Walker RH, Tse W, Sano M, Pereira AC, Ahfeldt T, Goate AM, Bressman S, Crary JF, De Witte L, Frucht S, Saunders-Pullman R, Raj T. Nat Aging. 2021 Sep;1(9):850-863.
  21. Genetic analysis of the human microglial transcriptome across brain regions, aging and disease pathologies. Lopes KP, Snijders GJL, Humphrey J, Allan A, Sneeboer MAM, Navarro E, Schilder BM, Vialle RA, Parks M, Missall R, van Zuiden W, Gigase FAJ, Kübler R, van Berlekom AB, Hicks EM, Bӧttcher C, Priller J, Kahn RS, De Witte LD, Raj T. Nat Genet. 2022 Jan;54(1):4-17.
  22. Transcriptomic and functional analysis of Aβ1-42 oligomer-stimulated human monocyte-derived microglia-like cells. Smit T, Ormel PR, Sluijs JA, Hulshof LA, Middeldorp J, De Witte LD, Hol EM, Donega V. Brain Behav Immun. 2022 Feb;100:219-230.
  23. Cerebrospinal fluid abnormalities in first- and multi-episode schizophrenia-spectrum disorders: impact of clinical and demographical variables. Oviedo-Salcedo T, Wagner E, Campana M, Gagsteiger A, Strube W, Eichhorn P, Louiset ML, Luykx J, De Witte LD, Kahn RS, Benros ME, Falkai P, Hasan A. Transl Psychiatry. 2021 Dec 8;11(1):621.
  24. SARS-CoV-2 during pregnancy and associated outcomes: Results from an ongoing prospective cohort. Molenaar NM, Rommel AS, De Witte L, Dolan SM, Lieb W, Ibroci E, Ohrn S, Lynch J, Capuano C, Stadlbauer D, Krammer F, Zapata LB, Brody RI, Pop VJ, Jessel RH, Sperling RS, Afzal O, Gigase F, Missall R, Janevic T, Stone J, Howell EA, Bergink V. Paediatr Perinat Epidemiol. 2022 Jul;36(4):466-475.
  25. DNA methylation differences in cortical grey and white matter in schizophrenia. Berdenis van Berlekom A, Notman N, Sneeboer MA, Snijders GJ, Houtepen LC, Nispeling DM, He Y, Dracheva S, Hol EM, Kahn RS, De Witte LD, Boks MP; Psychiatric Donor Program of the Netherlands Brain Bank (NBB-PSY). Epigenomics. 2021 Aug;13(15):1157-1169.
  26. The effect of prednisolone on symptom severity in schizophrenia: A placebo-controlled, randomized controlled trial. Nasib LG, Gangadin SS, Rossum IW, Boudewijns ZSRM, De Witte LD, Wilting I, Luykx J, Somers M, Veen N, van Baal C, Kahn RS, Sommer IE. Schizophr Res. 2021 Mar 9;230:79-86.
  27. Simvastatin Augmentation for Patients With Early-Phase Schizophrenia-Spectrum Disorders: A Double-Blind, Randomized Placebo-Controlled Trial. Sommer IE, Gangadin SS, De Witte LD, Koops S, van Baal C, Bahn S, Drexhage H, van Haren NEM, Veling W, Bruggeman R, Martens P, Wiersma S, Veerman SRT, Grootens KP, van Beveren N, Kahn RS, Begemann MJH. Schizophr Bull. 2021 Feb
  28. Fully defined human pluripotent stem cell-derived microglia and tri-culture system model C3 production in Alzheimer’s disease. Guttikonda SR, Sikkema L, Tchieu J, Saurat N, Walsh RM, Harschnitz O, Ciceri G, Sneeboer M, Mazutis L, Setty M, Zumbo P, Betel D, De Witte LD, Pe’er D, Studer L. Nat Neurosci. 2021 Feb 8. doi: 10.1038/s41593-020-00796-z. PMID: 33558694
  29. A loss of mature microglial markers without immune activation in schizophrenia. Snijders GJLJ, van Zuiden W, Sneeboer MAM, Berdenis van Berlekom A, van der Geest AT, Schnieder T, MacIntyre DJ, Hol EM, Kahn RS, De Witte LD. Glia. 2021 Jan 7. doi: 10.1002/glia.23962. PMID: 33410555
  30. Distinct non-inflammatory signature of microglia in post-mortem brain tissue of patients with major depressive disorder. Snijders GJLJ, Sneeboer MAM, Fernández-Andreu A, Udine E; Psychiatric donor program of the Netherlands Brain Bank (NBB-Psy), Boks MP, Ormel PR, van Berlekom AB, van Mierlo HC, Bӧttcher C, Priller J, Raj T, Hol EM, Kahn RS, De Witte LD. Mol Psychiatry. 2020 Oct 7
  31. Single-cell mass cytometry of microglia in major depressive disorder reveals a non-inflammatory phenotype with increased homeostatic marker expression. Böttcher C, Fernández-Zapata C, Snijders GJL, Schlickeiser S, Sneeboer MAM, Kunkel D, De Witte LD, Priller J. Transl Psychiatry. 2020 Sep 11;10(1):310.
  32. A characterization of the molecular phenotype and inflammatory response of schizophrenia patient-derived microglia-like cells. Ormel PR, Böttcher C, Gigase FAJ, Missall RD, van Zuiden W, Fernández Zapata MC, Ilhan D, de Goeij M, Udine E, Sommer IEC, Priller J, Raj T, Kahn RS, Hol EM, De Witte LD. Brain Behav Immun. 2020 Nov;90:196-207
  33. Cannabinoids and psychotic symptoms: A potential role for a genetic variant in the P2X purinoceptor 7 (P2RX7) gene. Boks MP, He Y, Schubart CD, Gastel WV, Elkrief L, Huguet G, Eijk KV, Vinkers CH, Kahn RS, Paus T, Conrod P, Hol EM, De Witte LD. Brain Behav Immun. 2020 Apr 21:S0889-1591(19)31328-5. doi: 10.1016/j.bbi.2020.04.051. PMID: 32330591
  34. No association between anti-thyroidperoxidase antibodies and bipolar disorder: a study in the Dutch Bipolar Cohort and a meta-analysis. Snijders GJLJ, De Witte LD, van den Berk D, van der Laan C, Regeer E, Begemann MJH, Berdenis van Berlekom A, Litjens M, Boks MP, Ophoff RA, Kahn RS, Hillegers MHJ. Psychoneuroendocrinology. 2020 Feb;112:104518. doi: 10.1016/j.psyneuen.2019.104518. Epub 2019 Nov 16. PMID: 31780186
  35. B-cells and schizophrenia: A promising link or a finding lost in translation? van Mierlo HC, Broen JCA, Kahn RS, De Witte LD. Brain Behav Immun. 2019 Oct;81:52-62. doi: 10.1016/j.bbi.2019.06.043. Epub 2019 Jul 2.
  36. The association between antibodies to neurotropic pathogens and bipolar disorder : A study in the Dutch Bipolar (DB) Cohort and meta-analysis. Snijders GJLJ, van Mierlo HC, Boks MP, Begemann MJH, Sutterland AL, Litjens M, Ophoff RA, Kahn RS, De Witte LD. Transl Psychiatry. 2019 Nov 20;9(1):311
  37. Microglial activation in schizophrenia: Is translocator 18 kDa protein (TSPO) the right marker? Sneeboer MAM, van der Doef T, Litjens M, Psy NBB, Melief J, Hol EM, Kahn RS, De Witte LD. Schizophr Res. 2019 Nov 4. pii: S0920-9964(19)30480-3. doi: 10.1016/j.schres.2019.10.045.
  38. Increased number of T-lymphocytes in post-mortem brain tissue of patients with schizophrenia. Sneeboer MAM, van Mierlo HC, Stotijn E, MacIntyre DJ, Smith C, Kahn RS, Hol EM, De Witte LD. Schizophr Res. 2019 Oct 29. 
  39. CSF-1 controls cerebellar microglia and is required for motor function and social interaction. Kana V, Desland FA, Casanova-Acebes M, Ayata P, Badimon A, Nabel E, Yamamuro K, Sneeboer M, Tan IL, Flanigan ME, Rose SA, Chang C, Leader A, Le Bourhis H, Sweet ES, Tung N, Wroblewska A, Lavin Y, See P, Baccarini A, Ginhoux F, Chitu V, Stanley ER, Russo SJ, Yue Z, Brown BD, Joyner AL, De Witte LD, Morishita H, Schaefer A, Merad M. J Exp Med. 2019 Oct 7;216(10):2265-2281. doi: 10.1084/jem.20182037. 
  40. Vitamin D concentration and psychotic disorder: associations with disease status, clinical variables and urbanicity. van der Leeuw C, De Witte LD, Stellinga A, van der Ley C, Bruggeman R, Kahn RS, van Os J, Marcelis M; for G.R.O.U.P. Psychol Med. 2019 Jul 22:1-7. doi: 10.1017/S0033291719001739. [Epub ahead of print]
  41. Neurons and glial cells in bipolar disorder: a systematic review of postmortem brain studies of cell number and size. Gigase FAJ, Snijders GJLJ, Boks MP, De Witte LD. Neurosci Biobehav Rev. 2019 Jun 1
  42. Synapse Pathology in Schizophrenia: A Meta-analysis of Postsynaptic Elements in Postmortem Brain Studies. Berdenis van Berlekom A, Muflihah CH, Snijders GJLJ, MacGillavry HD, Middeldorp J, Hol EM, Kahn RS, De Witte LD. Schizophr Bull. 2019 Jun 13. pii: sbz060. doi: 10.1093/schbul/sbz060
  43. DNA methylation changes related to nutritional deprivation: a genome-wide analysis of population and in vitro data. He Y, De Witte LD, Houtepen LC, Nispeling DM, Xu Z, Yu Q, Yu Y, Hol EM, Kahn RS, Boks MP. Clin Epigenetics. 2019 May 16;11(1):80. doi: 10.1186/s13148-019-0680-7.
  44. Microglia in post-mortem brain tissue of patients with bipolar disorder are not immune activated.Sneeboer MAM, Snijders GJLJ, Berdowski WM, Fernández-Andreu A; Psychiatric Donor Program of the Netherlands Brain Bank (NBB-Psy), van Mierlo HC, Berdenis van Berlekom A, Litjens M, Kahn RS, Hol EM, De Witte LD.Transl Psychiatry. 2019 May 24;9(1):153. doi: 10.1038/s41398-019-0490-x.
  45. The association between schizophrenia and the immune system: Review of the evidence from unbiased ‘omic-studies’.van Mierlo HC, Schot A, Boks MPM, De Witte LD. Schizophr Res. 2019 May 23. pii: S0920-9964(19)30204-X. doi: 10.1016/j.schres.2019.05.028.
  46. Liprin alfa 2 gene expression is increased by cannabis use and associated with neuropsychological function. He Y, De Witte LD, Schubart CD, Van Gastel WA, Koeleman BPC, de Jong S, Ophoff RA, Hol EM, Boks MP. Eur Neuropsychopharmacol. 2019 Mar 14. pii: S0924-977X(19)30192-0. doi: 10.1016/j.euroneuro.2019.03.004. PMID: 30879928
  47. Childhood Adversity Is Associated With Increased KITLG Methylation in Healthy Individuals but Not in Bipolar Disorder Patients. He Y, Vinkers CH, Houtepen LC, De Witte LD, Boks MP. Front Psychiatry. 2019 Jan 22;9:743. doi: 10.3389/fpsyt.2018.00743. eCollection 2018. PMID: 30723428
  48. Human microglia regional heterogeneity and phenotypes determined by multiplexed single-cell mass cytometry. Böttcher C, Schlickeiser S, Sneeboer MAM, Kunkel D, Knop A, Paza E, Fidzinski P, Kraus L, Snijders GJL, Kahn RS, Schulz AR, Mei HE; NBB-Psy, Hol EM, Siegmund B, Glauben R, Spruth EJ, De Witte LD, Priller J. Nature Neurosci. 2019 Jan;22(1):78-90. doi: 10.1038/s41593-018-0290-2. Epub 2018 Dec 17. PMID: 30559476
  49. Handboek Schizofrenie: Diagnostiek naar somatische oorzaken, De Witte LD, De Jel D, Van Mierlo H, De Witte MA, Cahn W, Luykx J, Vinkers C. Handboek Schizofrenie, De Tijdstroom, 2019
  50. Handboek Schizofrenie: Biologische risicofactoren. Van Winkel R, De Witte LD, Marcelis M. Handboek Schizofrenie, De Tijdstroom, 2019
  51. Handboek Schizofrenie: Het Immuunsysteem. Van Mierlo HC, De Witte LD. Handboek Schizofrenie, De Tijdstroom, 2019
  52. Microglia innately develop within cerebral organoids. Ormel PR, Vieira de Sá R, van Bodegraven EJ, Karst H, Harschnitz O, Sneeboer MAM, Johansen LE, van Dijk RE, Scheefhals N, Berdenis van Berlekom A, Ribes Martínez E, Kling S, MacGillavry HD, van den Berg LH, Kahn RS, Hol EM*, De Witte LD*, Pasterkamp RJ* Nature Commun. 2018 Oct 9;9(1):4167. doi: 10.1038/s41467-018-06684-2.PMID: 3030188
  53. Genetic vulnerability to DUSP22 promoter hypermethylation is involved in the relation between in utero famine exposure and schizophrenia. Boks MP, Houtepen LC, Xu Z, He Y, Ursini G, Maihofer AX, Rajarajan P, Yu Q, Xu H, Wu Y, Wang S, Shi JP, Hulshoff Pol HE, Strengman E, Rutten BPF, Jaffe AE, Kleinman JE, Baker DG, Hol EM, Akbarian S, Nievergelt CM, De Witte LD, Vinkers CH, Weinberger DR, Yu J, Kahn RS. NPJ Schizophr. 2018 Aug 21;4(1):16. doi: 10.1038/s41537-018-0058-4.PMID: 30131491
  54. Is psychiatry ready to let patients review their own files? Inventory of initial experiences. van Veen SMP, Mostert M, De Witte L, Somers M. Tijdschr Psychiatr. 2018;60(5):333-337. Dutch. PMID: 29766481
  55. Absence of cerebrospinal fluid antineuronal antibodies in schizophrenia spectrum disorders. Oviedo-Salcedo T, De Witte L, Kümpfel T, Kahn RS, Falkai P, Eichhorn P, Luykx J, Hasan A. Br J Psychiatry. 2018 May;212(5):318-320. PMID: 29587895 DOI: 10.1192/bjp.2018.24 
  56. Virus discovery analyses on post-mortem brain tissue and cerebrospinal fluid of schizophrenia patients. Tomasik J, Smits SL, Leweke FM, Eljasz P, Pas S, Kahn RS, Osterhaus ADME, Bahn S, De Witte LD. Schizophrenia Research. 2018 Feb 22. PMID: 29478863 DOI: 10.1016/j.schres.2018.02.012
  57. In- and out-of-hospital emergency psychiatry: what is the best approach? Luykx JJ, Tijdink JK, Tempelaar W, Vinkers CH, De Witte L.  Ned Tijdschr Geneeskd. 2018;162(0):D2387. PMID: 29451111
  58. Are infectious agents involved in the pathogenesis of postpartum psychosis? De Witte LD, Snijders G, Litjens M Kamperman AM, Kushner SA, Kahn RS, Bergink V. J Affect Disord. 2018 Mar 15;229:141-144 PMID: 29310062 DOI: 10.1016/j.jad.2017.12.069
  59. No neuronal autoantibodies detected in plasma of patients with a bipolar I disorder; Snijders G, Titulaer MJ, Bergink V, Bastiaansen AE, Schreurs MWJ, Ophoff RA, Boks MP, Kahn RS, De Witte LD. Psychiatry research 2018 Jan;259:460-462. PMID: 29136601 DOI: 10.1016/j.psychres.2017.10.043
  60. Characterization of macrophages from schizophrenia patients; Ormel PR, van Mierlo HC, Litjens M, Strien MEV, Hol EM, Kahn RS, De Witte LD. NPJ Schizophr. 2017 Nov 14;3(1):41. PMID: 29138398 PMCID: PMC5686077 DOI: 10.1038/s41537-017-0042-4
  61. The seroprevalence of antithyroid peroxidase antibodies in bipolar families and bipolar twins: results from two longitudinal studies; Snijders G, De Witte L, Mesman E, Kemner S, Vonk R, Brouwer R, Nolen WA, Drexhage HA, Hillegers MHJ. Int J Bipolar Disord. 2017 Dec;5(1):1 PMID: 28108944 PMCID: PMC5250624 DOI: 10.1186/s40345-017-0070-z.
  62. Telomere quantification in frontal and temporal brain tissue of patients with schizophrenia; van Mierlo HC, Wichers CGK, He Y, Sneeboer MAM, Radstake TRDJ, Kahn RS, Broen JCA, De Witte LD. J Psychiatr Research 2017 Sep 7;95:231-234. PMID: 28910708 DOI: 10.1016/j.jpsychires.2017.09.006 
  63. Immune involvement in the pathogenesis of schizophrenia: a meta-analysis on postmortem brain studies; van Kesteren CF, Gremmels H, De Witte LD, Hol EM, Van Gool AR, Falkai PG, Kahn RS, Sommer IE. Translational Psychiatry 2017 Mar 28;7(3):e1075. PMID: 28350400 PMCID: PMC5404615 DOI: 10.1038/tp.2017.4
  64. Acute Boekje Psychiatrie; Luykx J, Tempelaar WM, Vinkers CH, Tijdink JK, De Witte LD, Van Zuiden, 2017 (www.acutepsychiatrie.com). Book in Dutch. 
  65. Clinical consequences of extensive routine laboratory investigations in patients with a recent onset psychotic disorder. van Mierlo HC, de Jel DV, Palmen SJ, van Veelen NM, Vinkers CH, De Witte LD. Schizophrenia Research 2017 Feb 2. PMID: 28162811 DOI: 10.1016/j.schres.2017.01.052
  66. In vivo (R)-[(11)C]PK11195 PET imaging of 18kDa translocator protein in recent onset psychosis. Van der Doef TF, De Witte LD, Sutterland AL, Jobse E, Yaqub M, Boellaard R, de Haan L, Eriksson J, NPJ Schizophrenia 2016 Aug 31;2:16031. PMID: 27602389 PMCID: PMC5007116 DOI: 10.1038/npjschz.2016.31
  67. Characterizing primary human microglia: A comparative study with myeloid subsets and culture models. Melief J, Sneeboer MA, Litjens M, Ormel PR, Palmen SJ, Huitinga I, Kahn RS, Hol EM, De Witte LD. Glia 2016 Jul 21. PMID: 27442614 DOI: 10.1002/glia.23023
  68. Aggression and restlessness following baclofen overdose. De Witte LD, Dekker D, Veraart J, Kromkamp M, Kaasjager K, Vinkers CH. Nederlands Tijdschrift voor Geneeskunde. 2016;160:A9604. PMID: 27484417
  69. Human glioblastoma-associated microglia/monocytes express a distinct RNA profile compared to human control and murine samples; Szulzewsky F, Arora S, De Witte L, Ulas T, Markovic D, Schultze JL, Holland E, Synowitz M, Wolf SA, Kettenmann H. Glia 2016 Aug;64(8):1416-36. PMID: 27312099 DOI: 10.1002/glia.23014
  70. No evidence for the presence of neuronal surface autoantibodies in plasma of patients with schizophrenia; van Mierlo HC, van Coevorden-Hameete MH, Munting LP, de Graaff E, De Witte L and the GROUP investigators. European Neuropsychopharmacology 2015 Dec;25(12):2326-32. PMID: 26482911 DOI: 10.1016/j.euroneuro.2015.09.017
  71. Early recognition of anti-N-methyl-D-aspartate receptor encephalitis in psychiatric patients. van Mierlo HC, Titulaer MJ, Kromkamp M, van de Kraats R, van Veelen NM, Palmen SJ, Kahn RS, De Witte LD. Acta Psychiatrica Scandinavica 2015 Oct;132(4):312-3. PMID: 26371800 DOI: 10.1111/acps.12471  
  72. The association between antibodies to neurotropic pathogens and schizophrenia: a case-control study; De Witte LD, van Mierlo HC, Litjens M, Klein HC, Bahn S, Osterhaus AD; GROUP Investigators. NPJ Schizophrenia 1, 15041 (2015). PMID: 27336045 PMCID: PMC4849462 DOI: 10.1038/npjschz.2015.41
  73. The prevalence of antinuclear antibodies in patients with schizophrenia spectrum disorders: results from a large cohort study; Van Mierlo HC, De Witte LD, Derksen RHWM, Otten HG and the GROUP investigators. NPJ Schizophrenia 1, 15013 (2015). PMID: 27336030 PMCID: PMC4849444 DOI: 10.1038/npjschz.2015.13
  74. Absence of N-Methyl-D-Aspartate Receptor IgG Autoantibodies in Schizophrenia; De Witte LD, Hoffmann C, van Mierlo HC, Titulaer MJ, Kahn RS, Martinez-Martinez P; European Consortium of Autoimmune Mental Disorders (CAIMED). JAMA psychiatry 2015 Jul;72(7):731-3. PMID: 25970159 DOI: 10.1001/jamapsychiatry.2015.0526 
  75. Microglia activation, herpes infection, and NMDA receptor inhibition: common pathways to psychosis? Klein HC, Doorduin J, De Witte L, de Vries EJF. Book chapter Immunology and Psychiatry, 2015 – Springer
  76. Cushing’s syndrome in a manic patient with a long-standing bipolar disorder: cause or coincidence? De Witte LD, Smits RB, Bartel M, Kleijweg M, Valk GD, Vinkers CH, Vergeer M Tijdschrift voor Psychiatrie 57 (2015) 10, 757 – 761. PMID: 26479256
  77. Auto-immune encephalitis in psychiatric practice; De Witte L, Kromkamp M, Schoenmaker N, van Mierlo HC, Martinez-Martínez P, Palmen SJ, Sommer IE. Tijdschrift voor Psychiatrie 57 (2015) 6, 446 – 451. PMID: 26073839
  78. Severe chronic psychosis after allogeneic SCT from a schizophrenic sibling; Sommer IE, van Bekkum DW, Klein H, Yolken R, De Witte L, Talamo G. Bone Marrow Transplantation 2015 Jan;50(1):153-4. PMID: 25285805 PMCID: PMC4287892 DOI: 10.1038/bmt.2014.221
  79. Auto-immune disorders as a possible cause of neuropsychiatric syndromes; Martinez-Martinez P, Molenaar PC, Losen M, Hoffmann C, Stevens J, De Witte LD, van Amelsvoort T, van Os J, Rutten BP. Tijdschrift voor Psychiatrie 2015;57(3):183-91. PMID: 25856741
  80. Longitudinal changes of telomere length and epigenetic age related to traumatic stress and post-traumatic stress disorder. Boks MP, van Mierlo HC, Rutten BP, Radstake TR, De Witte L, Geuze E, Horvath S, Schalkwyk LC, Vinkers CH, Broen JC, Vermetten E. Psychoneuroendocrinology. 2015 Jan;51:506-12. doi: 10.1016. PMID: 25129579 DOI: 10.1016/j.psyneuen.2014.07.011
  81. Glioblastoma-derived extracellular vesicles modify the phenotype of monocytic cells;  de Vrij J, Maas SL, Kwappenberg KM, Schnoor R, Kleijn A, Dekker L, Luider TM, De Witte LD, Litjens M, van Strien ME, Hol EM, Kroonen J, Robe PA, Lamfers ML, Schilham MW, Broekman ML.  International Journal of Cancer 2015 Mar 20. PMID: 25802036 DOI: 10.1002/ijc.29521
  82. PET Imaging of Microglia Activation in Neuropsychiatric Disorders with Potential Infectious Origin, PET and SPECT in Neurology, Klein HC, De Witte LD, Bransfield R, de Deyn RP, Book chapter. Springer 2014
  83. Genetic liability for schizophrenia predicts risk of immune disorders; Stringer S, Kahn RS, De Witte LD, Ophoff RA, Derks EM. Schizophrenia Research 2014 Nov;159(2-3):347-52. PMID: 25266548 DOI: 10.1016/j.schres.2014.09.004
  84. Cannabidiol as a potential treatment for psychosis; Schubart CD, Sommer IE, Fusar-Poli P, De Witte L, Kahn RS, Boks MP. European Neuropsychopharmacology 2014 Jan;24(1):51-64. PMID: 24309088 DOI: 10.1016/j.euroneuro.2013.11.002
  85. Efficacy of anti-inflammatory agents to improve symptoms in patients with schizophrenia: an update; Sommer IE, van Westrhenen R, Begemann MJ, De Witte LD, Leucht S, Kahn RS. Schizophrenia Bulletin 2014 Jan;40(1):181-9. PMID: 24106335 PMCID: PMC3885306 DOI: 10.1093/schbul/sbt139
  86. Caveolin-1 mediated uptake via langerin restricts HIV-1 infection in human Langerhans cells; van den Berg LM, Ribeiro CM, Zijlstra-Willems EM, De Witte L, Fluitsma D, Tigchelaar W, Everts V, Geijtenbeek TB. Retrovirology 2014 Dec 31;11(1):3903. PMID: 25551286 PMCID: PMC4301922 DOI: 10.1186/s12977-014-0123-7
  87. Cytokine alterations in first-episode schizophrenia patients before and after antipsychotic treatment; De Witte L, Tomasik J, Schwarz E, Guest PC, Rahmoune H, Kahn RS, Bahn S. Schizophrenia Research 2014 Apr;154(1-3):23-9. PMID: 24582037 DOI: 10.1016/j.schres.2014.02.005
  88. Nonsteroidal anti-inflammatory drugs in schizophrenia: ready for practice or a good start? A meta-analysis; Sommer IE, De Witte L, Begemann M, Kahn RS. Journal of Clinical Psychiatry. 2012 Apr;73(4):414-9. PMID: 22225599 DOI: 10.4088/JCP.10r06823
  89. Human Langerhans cells capture measles virus through Langerin and present viral antigens to CD4(+) T cells but are incapable of cross-presentation; van der Vlist M, De Witte L, de Vries RD, Litjens M, de Jong MA, Fluitsma D, de Swart RL, Geijtenbeek TB. Europen Journal of Immunology 2011 Jul 8. PMID: 21739428 DOI: 10.1002/eji.20104130
  90. HSV Neutralization by the Microbicidal Candidate C5A; De Witte L, Bobardt MD, Chatterji U, van Loenen FB, Verjans GM, Geijtenbeek TB, Gallay PA. PLoS One. 2011 May 6;6(5):e18917.  PMID: 21573158 PMCID: PMC3089603 DOI: 10.1371/journal.pone.0018917
  91. Burn injury suppresses human dermal dendritic cell and Langerhans cell function; van den Berg LM, de Jong MA, De Witte LD, Ulrich MM, Geijtenbeek TB. Cellular Immunology 2011;268(1):29-36. PMID: 21345420 DOI: 10.1016/j.cellimm.2011.01.007 
  92. Streptococcus pneumoniae exposure is associated with human metapneumovirus seroconversion and increased susceptibility to in vitro HMPV infection;  Verkaik NJ, Nguyen DT, de Vogel CP, Moll HA, Verbrugh HA, Jaddoe VW, Hofman A, van Wamel WJ, van den Hoogen BG, Buijs-Offerman RM, Ludlow M, De Witte L, Osterhaus AD, van Belkum A, de Swart RL. Clinical Microbiology and infection. 2011 Dec;17(12):1840-4. PMID: 21883660 DOI: 10.1111/j.1469-0691.2011.03480.x
  93. Isolation of immature primary Langerhans cells from human epidermal skin; De Witte L, de Jong MA, Geijtenbeek TB. Methods Molecular Biololgy 2010;595:55-65. PMID: 19941105 DOI: 10.1007/978-1-60761-421-0_4 
  94. The Synthetic Bacterial Lipopeptide Pam3CSK4 Modulates Respiratory Syncytial Virus Infection Independent of TLR Activation; Nguyen DT, De Witte L, Ludlow M, Yüksel S, Wiesmüller KH, Geijtenbeek TB, Osterhaus AD, de Swart RL. Plos Pathogens 2010 Aug 19;6(8). PMID: 20808895 PMCID: PMC2924323 DOI: 10.1371/journal.ppat.1001049 
  95. Mutz-3-derived Langerhans cells are a model to study HIV-1 transmission and potential inhibitors; de Jong MA, De Witte L, Santegoets SJ, Fluitsma D, Taylor ME, de Gruijl TD, Geijtenbeek TB. Journal of Leukocyte Biology 2010 apr;87(4):637-43. PMID: 20042470 DOI: 10.1189/jlb.0809577 
  96. Herpes Simplex Virus Type 2 Enhances HIV-1 Susceptibility by Affecting Langerhans Cell Function; de Jong MA, De Witte L, Taylor ME, Geijtenbeek TB. Journal of Immunology 2010 aug 1;185(3):1633-41. PMID: 20592277 DOI: 10.4049/jimmunol.0904137 
  97. Syndecan-Fc Hybrid Molecule as a Potent In Vitro Microbicidal Anti-HIV-1 Agent; Bobardt MD, Chatterji U, Schaffer L, De Witte L, Gallay PA. Antimicrobial agents and chemotherapy 2010 Jul;54(7):2753-66. PMID: 20439611 PMCID: PMC2897270 DOI: 10.1128/AAC.01606-09 
  98. Identification of pathogen receptors on dendritic cells to understand their function and to identify new drug targets; De Witte L, de Jong MA, den Dunnen J, van Kooyk Y, Geijtenbeek TB. Methods Molecular Biology 2009;531:267-85. PMID: 19347323 DOI: 10.1007/978-1-59745-396-7_17
  99. Dendritic cells mediate herpes simplex virus infection and transmission through the C-type lectin DC-SIGN; De Witte L, de Jong MA, Bolmstedt A, van Kooyk Y, Geijtenbeek TB. Journal of General Virology. 2008 Oct;89:2398-409. PMID: 18796707 DOI: 10.1099/vir.0.2008/003129-0
  100. DC-SIGN and CD150 have distinct roles in transmission of measles virus from dendritic cells to T-lymphocytes; De Witte L, de Vries RD, van der Vlist M, Yüksel S, Litjens M, de Swart RL, Geijtenbeek TB. PLoS Pathogens. 2008 Apr 18;4(4):e1000049. PMID: 18421379 PMCID: PMC2277461 DOI: 10.1371/journal.ppat.1000049
  101. TNF-alpha and TLR agonists increase susceptibility to HIV-1 transmission by human Langerhans cells ex vivo; De Witte L, de Jong MA, Oudhoff MJ, Gringhuis SI, Gallay P, Geijtenbeek TB. Journal of Clinical Investigations. 2008 Oct;118(10):3440-52. PMID: 18776939 PMCID: PMC2528910 DOI: 10.1172/JCI34721 
  102. C-type lectin Mermaid inhibits dendritic cell mediated HIV-1 transmission to CD4+ T cells; Nabatov AA, de Jong MA, De Witte L, Bulgheresi S, Geijtenbeek TB. Virology 2008 Sep 1;378(2):323-8.  PMID: 18597806 DOI: 10.1016/j.virol.2008.05.025
  103. Hepatitis C virus NS5A anchor peptide disrupts human immunodeficiency virus; Bobardt MD, Cheng G, De Witte L, Selvarajah S, Chatterji U, Sanders-Beer BE, Geijtenbeek TB, Chisari FV, Gallay PA. Proceedings of the National Academy of Sciences  2008 Apr 8;105(14):5525-30. PMID: 18378908 PMCID: PMC2291127 DOI: 10.1073/pnas.0801388105 
  104. Binding of Human Papilloma Virus L1 Virus-like particles to dendritic cells is mediated through heparan sulfates and induces immune activation; De Witte L, Zoughlami Y, Aengeneyndt B, David G, van Kooyk Y, Gissmann L, Geijtenbeek TB. Immunobiology 2008;212(9-10):679-91. PMID: 18086370 DOI: 10.1016/j.imbio.2007.09.006  
  105. Distinct roles for DC-SIGN(+)-dendritic cells and Langerhans cells in HIV-1 transmission; De Witte L, Nabatov A, Geijtenbeek TB. Trends Molecular Medicine 2008 Jan;14(1):12-9. PMID: 18055263 DOI: 10.1016/j.molmed.2007.11.001
  106. Langerin is a natural barrier to HIV-1 transmission by Langerhans cells; De Witte L, Nabatov A, Pion M, Fluitsma D, de Jong MA, de Gruijl T, Piguet V, van Kooyk Y, Geijtenbeek TB. Nature medicine 2007 Mar;13(3):367-71. PMID: 17334373 DOI: 10.1038/nm1541  
  107. Predominant infection of CD150+ lymphocytes and dendritic cells during measles virus infection of macaques; de Swart RL, De Witte L, Ludlow M, Yanagi Y, van Amerongen G, McQuaid S, Yüksel S, Geijtenbeek TB, Duprex WP, Osterhaus AD. Plos Pathogens 2007 Nov;3(11):e178. PMID: 18020706 PMCID: PMC2077902 DOI: 10.1371/journal.ppat.0030178 
  108. Syndecan-3 is a dendritic cell-specific attachment receptor for HIV-1; De Witte L, Bobardt M, Chatterji U, Degeest G, David G, Geijtenbeek TB, Gallay P. Proceedings of the National Academy of Sciences  2007 Dec 4;104(49):19464-9. PMID: 18040049 PMCID: PMC2148312 DOI: 10.1073/pnas.0703747104 
  109. Dendritic Cell mediated viral transmission: A Potential Drug target?; De Witte LD, Geijtenbeek THB. Future Virology 2006 sep. doi.org/10.2217/17460794.1.5.615  
  110. Measles virus targets DC-SIGN to enhance dendritic cell infection; De Witte L, Abt M, Schneider-Schaulies S, van Kooyk Y, Geijtenbeek TBH. Journal of Virology 2006 Apr;80(7):3477-86. PMID: 16537615 PMCID: PMC1440360 DOI: 10.1128/JVI.80.7.3477-3486.2006 
  111. Pathogen interactions with DC-SIGN modulate immune responses: A Toll tale?; De Witte LD, Geijtenbeek THB. Curr. Immunology Reviews. 2005 jun; 1(2) 165-173. https://doi.org/10.2174/1573395054065133 
  112. Excess risk for contralateral breast cancer in CHEK2*1100delC germline mutation carriers; Broeks A, De Witte L, Nooijen A, Huseinovic A, Klijn JG, van Leeuwen FE, Russell NS, van’t Veer LJ. Broeks et al. Breast Cancer Research Treatment 2004 Jan;83(1):91-3. PMID: 14997059 DOI: 10.1023/B:BREA.0000010697.49896.0